Global central banks deliver historic rate hike blast in 2022

Author of the article: Reuters Karin Strohecker and Vincent Flasseur Published Dec 26, 2022  •  2 minute read Join the conversation LONDON — Major central banks ramped up interest rates at the fastest pace and biggest scale in at least two decades in 2022 as policy makers went all out in the battle to contain…
Global central banks deliver historic rate hike blast in 2022

Author of the article:

Reuters

Karin Strohecker and Vincent Flasseur

Published Dec 26, 2022  •  2 minute read

Join the conversation

LONDON — Major central banks ramped up interest rates at the fastest pace and biggest scale in at least two decades in 2022 as policy makers went all out in the battle to contain surging inflation.

Central banks overseeing the 10 most heavily traded currencies delivered 2,700 basis points (bps) of tightening in 54 rate hikes over the past 12 months, Reuters calculations show.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails or any newsletter. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

All major central banks bar the Bank of Japan raised rates this year, though policymakers in Tokyo roiled markets in December with a surprise policy tweak to its yield target, fueling speculations that an actual rate hike might be on the cards in the not too distant future.

However, it was primarily the U.S. Federal Reserve’s 225 basis points of hikes over the past 12 months – and the prospect of possibly more to come – that has kept markets on edge against a backdrop of sharply slowing growth.

“When you look at the tightening in the U.S. it is basically one of the sharpest ever in the past 20 years,” David Hauner, head of emerging markets cross-asset strategy and economics, EMEA at Bank of America Global Research told Reuters.

“Normally when you have such a sharp tightening in financial conditions you basically have something more than just a small recession, which seems now the general consensus.”

On a monthly basis, data showed that seven out of the 10 major central banks lifted rates in December.

The U.S. Federal Reserve, the European Central Bank, the Bank of England, the Reserve Bank of Australia, Norway’s Norges Bank, the Bank of Canada and the Swiss National Bank all raised their benchmarks by a cumulative of 300 basis points. This compares to the monthly peak of 550 bps in September, though not all central banks meet on a monthly basis.

The Reserve Bank of New Zealand and Sweden’s Riksbank did not hold rate setting meetings in December.

Meanwhile, there was more evidence that the tightening cycle in emerging markets was slowing down.

Five out of 18 central banks delivered a total 260 bps of rate hikes in December, down from 400 bps in November and some way off the 800-plus bps monthly tallies in June and July.

The majority of those came from policymakers in Asia, who are lagging in the tightening cycle Latin America and emerging Europe. Central banks in Indonesia, India and the Philippines raised rates, alongside Colombia and Mexico.

“Most emerging market central banks are close to having completed their rate hike cycle,” said Charles-Henry Moncheau, chief investment office at Syz Group.

Emerging market central banks have raised rates 93 times this year to lift benchmarks by a total of 7,425 bps this year, nearly three times the 2,745 bps tightening in 2021, calculations show.

Central banks in Korea, South Africa, Thailand, Malaysia and Israel did not hold rate setting meetings in December.

(Reporting by Karin Strohecker and Vincent Flasseur in London, editing by Tomasz Janowski)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Lucidea’s Archival CMS ArchivEra at ACA 2023
Read More

Lucidea’s Archival CMS ArchivEra at ACA 2023

Author of the article: Published Jun 22, 2023  •  1 minute read VANCOUVER, British Columbia — Lucidea, provider of ArchivEra archival collections management software is attending and sponsoring the Association of Canadian Archivists (ACA) conference on June 28th through July 1st. Lucidea’s innovative and adaptable archival collections management solutions enable researchers and the public to…
Wall St ends little changed as J&J, Goldman disappoint
Read More

Wall St ends little changed as J&J, Goldman disappoint

Author of the article: Reuters Lewis Krauskopf and Sruthi Shankar and Ankika Biswas Published Apr 18, 2023  •  2 minute read The S&P 500 ended little changed on Tuesday after a mixed performance from megacap stocks and disappointing quarterly reports from Johnson & Johnson and Goldman Sachs as first-quarter earnings season kicked into gear. J&J…
Open banking presents ‘an opportunity, not a problem’ for credit unions, Meridian CEO says
Read More

Open banking presents ‘an opportunity, not a problem’ for credit unions, Meridian CEO says

Credit unions have an edge over big banks when it comes to sharing data across the financial landscape, says Jay-Ann Gilfoy Bank buildings in the financial district in Toronto. Photo by REUTERS/Mark Blinch/File Photo Meridian Credit Union Ltd. is looking at open banking as “an opportunity, not a problem,” says Jay-Ann Gilfoy, who took over…
Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome
Read More

Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome

Author of the article: Published Jul 21, 2023  •  Last updated 16 hours ago  •  9 minute read Positive opinion from Committee for Medicinal Products for Human Use (CHMP) based on Bylvay Phase III ASSERT clinical-trial data in Alagille syndrome (ALGS) Negative opinion from Committee for Orphan Medicinal Products (COMP) recommending not to maintain orphan drug…